Alethia Biotherapeutics
- Headquarters
- Montreal
- Employees
- 11–50
- Founded
- 2002
- Business Model
- B2B
- Website
- alethiabio.com
- Total Funding
- $16.5M
- Last Round
- $4.7M Series COct 2024
About
Alethia Biotherapeutics is a privately held, Montreal-based clinical-stage biotechnology company founded in 2002. The company is engaged in the discovery and development of therapeutic monoclonal antibodies against novel, clinically relevant targets in cancer and inflammatory diseases, with a focus on cancer-associated epithelial-to-mesenchymal transition (EMT) pathways.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account